Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0H3AB
|
|||
| Former ID |
DIB000290
|
|||
| Drug Name |
Incobotulinum toxin A
|
|||
| Synonyms |
IncobotulinumtoxinA; Xeomin; NT-201; Botulinum toxin type A extract (blepharospasm), Merz/BioteCon
Click to Show/Hide
|
|||
| Indication | Cervical cancer [ICD-11: 2C77.0; ICD-9: 180] | Approved | [1], [2] | |
| Company |
Merz
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Acetylcholine release (Ach rele) | Target Info | Modulator | [1], [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Mullard A: 2010 FDA drug approvals. Nat Rev Drug Discov. 2011 Feb;10(2):82-5. | |||
| REF 2 | Hughes B: 2009 FDA drug approvals. Nat Rev Drug Discov. 2010 Feb;9(2):89-92. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.